These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 18387672)
1. Neurotoxicity of MPTP to migrating neuroblasts: studies in acute and subacute mouse models of Parkinson's disease. He XJ; Yamauchi H; Uetsuka K; Nakayama H Neurotoxicology; 2008 May; 29(3):413-20. PubMed ID: 18387672 [TBL] [Abstract][Full Text] [Related]
2. Evidence of apoptosis in the subventricular zone and rostral migratory stream in the MPTP mouse model of Parkinson disease. He XJ; Nakayama H; Dong M; Yamauchi H; Ueno M; Uetsuka K; Doi K J Neuropathol Exp Neurol; 2006 Sep; 65(9):873-82. PubMed ID: 16957581 [TBL] [Abstract][Full Text] [Related]
3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease. Novikova L; Garris BL; Garris DR; Lau YS Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572 [TBL] [Abstract][Full Text] [Related]
4. Neural progenitor cells are protected against MPTP by MAO-B inhibitors. He XJ; Uetsuka K; Nakayama H Neurotoxicology; 2008 Nov; 29(6):1141-6. PubMed ID: 18606181 [TBL] [Abstract][Full Text] [Related]
5. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure fails to produce delayed degeneration of substantia nigra neurons in monkeys. Garrido-Gil P; Belzunegui S; San Sebastián W; Izal-Azcárate A; López B; Marcilla I; Luquin MR J Neurosci Res; 2009 Feb; 87(2):586-97. PubMed ID: 18798285 [TBL] [Abstract][Full Text] [Related]
6. Neurotrophic and neurorescue effects of Echinacoside in the subacute MPTP mouse model of Parkinson's disease. Zhao Q; Gao J; Li W; Cai D Brain Res; 2010 Jul; 1346():224-36. PubMed ID: 20478277 [TBL] [Abstract][Full Text] [Related]
7. Immunofluorescent labeling of increased calpain expression and neuronal death in the spinal cord of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice. Chera B; Schaecher KE; Rocchini A; Imam SZ; Sribnick EA; Ray SK; Ali SF; Banik NL Brain Res; 2004 May; 1006(2):150-6. PubMed ID: 15051518 [TBL] [Abstract][Full Text] [Related]
8. Cytosolic labile zinc accumulation in degenerating dopaminergic neurons of mouse brain after MPTP treatment. Lee JY; Son HJ; Choi JH; Cho E; Kim J; Chung SJ; Hwang O; Koh JY Brain Res; 2009 Aug; 1286():208-14. PubMed ID: 19559009 [TBL] [Abstract][Full Text] [Related]
9. Transiently impaired neurogenesis in MPTP mouse model of Parkinson's disease. He XJ; Nakayama H Neurotoxicology; 2015 Sep; 50():46-55. PubMed ID: 26215120 [TBL] [Abstract][Full Text] [Related]
10. Alteration in the differentiation-related molecular expression in the subventricular zone in a mouse model of Parkinson's disease. Oizumi H; Hayashita-Kinoh H; Hayakawa H; Arai H; Furuya T; Ren YR; Yasuda T; Seki T; Mizuno Y; Mochizuki H Neurosci Res; 2008 Jan; 60(1):15-21. PubMed ID: 17963913 [TBL] [Abstract][Full Text] [Related]
11. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B. Ito T; Suzuki K; Uchida K; Nakayama H Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658 [TBL] [Abstract][Full Text] [Related]
12. Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity. Liang Y; Li S; Guo Q; Zhang Y; Wen C; Zou Q; Su B Brain Res; 2007 Oct; 1178():132-40. PubMed ID: 17900537 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human granulocyte colony-stimulating factor protects against MPTP-induced dopaminergic cell death in mice by altering Bcl-2/Bax expression levels. Cao XQ; Arai H; Ren YR; Oizumi H; Zhang N; Seike S; Furuya T; Yasuda T; Mizuno Y; Mochizuki H J Neurochem; 2006 Nov; 99(3):861-7. PubMed ID: 17076657 [TBL] [Abstract][Full Text] [Related]
14. Resistance of the golden hamster to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-neurotoxicity is not only related with low levels of cerebral monoamine oxidase-B. Rodríguez S; Ito T; He XJ; Uchida K; Nakayama H Exp Toxicol Pathol; 2013 Jan; 65(1-2):127-33. PubMed ID: 21795029 [TBL] [Abstract][Full Text] [Related]
15. Tripchlorolide protects against MPTP-induced neurotoxicity in C57BL/6 mice. Hong Z; Wang G; Gu J; Pan J; Bai L; Zhang S; Chen SD Eur J Neurosci; 2007 Sep; 26(6):1500-8. PubMed ID: 17714494 [TBL] [Abstract][Full Text] [Related]
16. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse. Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248 [TBL] [Abstract][Full Text] [Related]
17. Transplantation of human amniotic cells exerts neuroprotection in MPTP-induced Parkinson disease mice. Kong XY; Cai Z; Pan L; Zhang L; Shu J; Dong YL; Yang N; Li Q; Huang XJ; Zuo PP Brain Res; 2008 Apr; 1205():108-15. PubMed ID: 18353283 [TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of benzylideneacetophenone derivative on the MPTP model of neurodegeneration in mice. Kang JM; Jung JC; Kim H; Lim H; Jang S; Oh S Arch Pharm Res; 2008 Sep; 31(9):1098-107. PubMed ID: 18806951 [TBL] [Abstract][Full Text] [Related]
19. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice. Aoki E; Yano R; Yokoyama H; Kato H; Araki T Exp Mol Pathol; 2009 Feb; 86(1):57-64. PubMed ID: 19027004 [TBL] [Abstract][Full Text] [Related]
20. Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease. Depboylu C; Schorlemmer K; Klietz M; Oertel WH; Weihe E; Höglinger GU; Schäfer MK J Neuroimmunol; 2011 Jul; 236(1-2):39-46. PubMed ID: 21640391 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]